Peripheral Arterial Disease Admissions CLI AND PAD ADMISSIONS.

Slides:



Advertisements
Similar presentations
Adult Medical-Surgical Nursing Endocrine Module: DM Footcare and Patient Teaching Plan.
Advertisements

Investigation of diabetic patients with chronic ulcers in the lower limb Non-healing wounds >2 months Biopsi from wond margin for biomarker analysis, stored.
Upper vs. Lower Body Aerobic Training in Patients with Claudication Diane Treat-Jacobson, PhD, RN Assistant Professor of Nursing Center for Gerontological.
30th Annual Interventional Cardiology Snowmass 3/3/15
PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.
Compression 1. Effects of External Compression Improved Venous and Lymphatic Circulation Limits the Shape and Size of Tissue 2.
Evolving Strategies in the Treatment of Peripheral Vascular Disease Ravish Sachar MD, FACC Wake Heart and Vascular.
Topical Oxygen Therapy
VENOUS DISEASE & CHRONIC VENOUS INSUFFICIENCY GEMP I Centre for Health Science Education Station 3.
PROGRESSION OF DIABETES MELLITUS IN THE WORLD Critical Limb Ischemia = Ischemic Diabetic Foot Critical Limb Ischemia = Ischemic Diabetic Foot Wild S et.
What is REGENERATIVE MEDICINE? “The regeneration or replacement of cells, tissues or organs to restore or establish normal function.” The goal is to.
PREDICTORS OF DIABETIC WOUND HEALING BY RACIAL/ETHNIC CATEGORIES Ranjita Misra 1, Lynn Lambert 2, David Vera 3, Ashley Mangaraj 3, Suchin R Khanna 3, Chandan.
This article and any supplementary material should be cited as follows: Mohajeri-Tehrani MR, Nasiripoor F, Torkaman G, Hedayati M, Annabestani Z, Asadi.
Positive Outcomes with Negative Pressure Wound Therapy Laurie S. Stelmaski BSN,RN,CWOCN.
VENOUS STASIS ULCERS. Venous stasis ulcer: occurs from chronic deep vein insufficiency and stasis of blood in the venous system of the legs An open, necrotic.
{ R. Diaz-Garcia MD, J. Bernardo MD Stem Cell Therapy for Patients with Critical Limb Ischemia: A Meta-analysis with Critical Limb Ischemia: A Meta-analysis.
CHRONIC WOUND TREATMENT. WHAT IS A WOUND AND HOW DOES OUR BODY REACT TO IT???????
Esiti del trattamento con angioplastica transluminale percutanea (PTA) agli arti inferiori nei pazienti diabetici in trattamento dialitico con ischemia.
1 E NHANCING THE BODY ’ S NATURAL H EALING AND R EGENERATIVE R ESOURCES.
BME- Short Presentation SHANTE DEZRICK 11/7/12. Common denominator in most common diseases. New capillary blood vessel growth in the body. Natural process.
Antibiotics Versus Conservative Surgery for Treating Diabetic Foot Osteomyelitis: A Randomized Comparative Trial Featured Article: José Luis Lázaro-Martínez,
Hyperbaric Oxygen Therapy
MidAtlantic Vascular, LLC Critical Limb Ischemia. P.A.D. Detection, Treatment, and Referral Paul Sasser MD FACS.
Obesity and type 2 diabetes The relationship between obesity and type 2 diabetes can be clearly seen in japanese Sumo wrestlers who are massively obese.
Wound Healing Dr. Raid Jastania.
Gene Therapy Prof. Dr. Marlina, MS, Apt Kuliah I 14 Maret 2011 Mata Kuliah: Bioteknologi Farmasi.
IB Biology HL 1 Mrs. Peters Fall Organization of Living Things Cells: either unicellular or multicellular Tissues: only in multicellular organisms,
Final Jeopardy Question Name that Tissue Epithelial 500 Conn- ective Tissue Repair Stem Cells Muscle
Tissue Repair.
Tissue Repair Kristine Krafts, M.D.. Tissue repair = restoration of tissue architecture and function after an injury Occurs in two ways: Regeneration.
Surgical Management of Diabetic Foot Ulcer
Cell Repair Therapy – Phase 1 Lessons Learned – Clinical Studies
Bill Marston, MD Professor and Chief, Division of Vascular Surgery
Improved Wound Management At Lower Cost: A Sensible Goal For Australia
A Biologic Approach for Myocardial Regeneration and Cardiac Recovery Leslie Miller, MD Leonhardt Launchpad, Utah.
MyStem® Autograft Preparation Kit
CHARACTERISTICS AND OUTCOME OF MAJOR LOWER LIMB AMPUTATIONS IN A TERTIARY CARE HOSPITAL Nishanthan A A, Sarangan S, Kalaventhan P, Prasath S, Gooneratne.
Amnion-derived Matrix FRAMEWORK FOR HEALING & REPAIR
Fig 1: Microscopic Spindle shaped MSCs Fig 2: Method of MSCs Injection
Healing, repair & regeneration Professor Dr. Wahda M.T. Al-Nuaimy
Presented By: Marieann McGhee
Multidisciplinary Approach for a Successful CLI Management Program
Circulation Looking after your legs!
MM McDermott and coauthors
© Topadur Pharma AG | Dezember 2017
Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial.
Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease by Ryuichi Morishita, Motokuni Aoki, Naotaka.
Peripheral Arterial Disease
Wound Healing- Part I Frequently, presenters must deliver material of a technical nature to an audience unfamiliar with the topic or vocabulary. The material.
Angiogenic properties of sustained release platelet-rich plasma: Characterization in-vitro and in the ischemic hind limb of the mouse  Shyamal Chandra.
Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice  Junji Moriya, MD, PhD, Xiumin Wu, PhD, Jose Zavala-Solorio,
miR93 for the treatment of peripheral arterial disease (PAD)
Volume 91, Issue 3, Pages (March 2017)
BMI: Regenerative Medicine
Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model  Abdulaziz Al-Khaldi, MD, Hilal.
In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia  Geoffrey O. Ouma,
Autologous bone marrow mononuclear cell therapy is safe and promotes amputation- free survival in patients with critical limb ischemia  Michael P. Murphy,
DB00102 Category : Angiogenesis Inducing Agents
Gait Biomechanics in Patients with Peripheral Artery Disease After Revascularization Sarah Bakera, Sara A. Myersa,c, Iraklis Pipinosb,c, and Jason Johanningb,c.
MOBILE Trial design: Patients with critical limb ischemia were randomized to intramuscular injection of bone marrow-derived stem cells (n = 119) vs. placebo.
Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34- positive endothelial cells in a hindlimb ischemia model: Implications for.
Nat. Rev. Cardiol. doi: /nrcardio
Cellular and molecular mechanism regulating blood flow recovery in acute versus gradual femoral artery occlusion are distinct in the mouse  Yagai Yang,
Volume 22, Issue 4, Pages (April 2014)
Volume 21, Issue 2, Pages (February 2013)
Volume 16, Issue 12, Pages (December 2008)
Volume 19, Issue 4, Pages (April 2011)
Appropriate control of ex vivo gene therapy delivering basic fibroblast growth factor promotes successful and safe development of collateral vessels in.
Post-ischemic vascular repair mechanisms and the growth factors involved. Post-ischemic vascular repair mechanisms and the growth factors involved. The.
Presentation transcript:

Peripheral Arterial Disease Admissions

CLI AND PAD ADMISSIONS

Critical Limb Ischemia Outcomes

CLI/PAD predominance in Medicare and Medicaid Population

TREATMENT OPTIONS FOR PAD/CLI SURGICAL REVASCULARIZATION CATHETER-BASED REVASCULARIZATION BIOELECTRIC STIMULATION STEM CELLS AMNIOTIC FLUID AND MEMBRANE GENE PLASMIDS

Bioelectric stimulation to Enhance Angiogenesis I. Isolated skeletal muscle cells Stimulated using the precise signal for VEGF Confirmed increase VEGF mRNA in medium Resulted in enhanced Endothelial cell activatioin II. Animal Model of hind limb ischemia* Bioelectric stimulation too low to cause muscle contraction or discomfort Induced demonstrable increase in blood flow and VEGF expression in the muscle. Simple and effective strategy to enhance expression of targeted proteins in the target tissue *Kanno et al Circulation 1999

VEGF mRNA Expression increased 480 % in Skeletal Muscle Increase in Capillary Density and VEGF Expression with Bioelectric Stimulation 230 % Increase P< 0.01 VEGF mRNA Expression increased 480 % in Skeletal Muscle Kanno S. Circ 1999 99:2682-91 Kanno S Circ 1999

BIOELETRIC STIMULATION FOR NON-HEALING WOUNDS DUE TO CLI Czech Republic 41 Patients with diabetes and non-healing leg or foot ulcers of various etiologies; arterial or venous, or pressure; all had std wound care Bioelectric stimulation for 45-60 minutes, 3 x’s/week for 8 weeks using 1.5 uA with cutaneous patch electrodes-induced no reported discomfort Over 90% Reduction in Wound Size by 8 weeks of this treatment. Wirsing et al internatl Wound J 2013

Patented Bioelectric Signals for Specific Target Proteins* SDF-1 Stem Cell Differentiating Signal VEGF Tropoelastin PDGF Activin A&B IGF Follistatin HGF eNOS EGF HIF-1 alpha Confirmed Expression in multiple tissues ONLY STRATEGY THAT STIMULATES HOMING/DIFFERENTIATION/PROLIFERATION

BIOELECTRIC STIMULATION FOR NON-HEALING ULCER

Bioelectric Stimulation for Non-Healing Wounds International Wound J 2014

BIOELETRIC STIMULATION FOR NON-HEALING DIABETIC FOOT ULCERS 30 Patients with wound ulcers unresponsive to all conventional therapies Randomized, single blind, placebo control trial Bioelectric stimulation: On or Off 1 hr sessions, 3 x’s/week, for 4 weeks (12 total) 60 % Reduction in Wound Area, vs 20% Control Wound fluid after 1 treatment showed significant increase in HIF-1 alpha levels p=0.01 vs Control Also significant increase VEGF with wound healing Asadi et al Diabetes Res 2017

Abadi Diabetes Res 2017

Amniotic Fluid and Membrane Fluid that bathes the fetus Readily available at C-Section deliveries Microarray analysis: 240 proteins-pro-regenerative and pro-angiogenic Membrane (chorion:amnion) lines uterine cavity Membrane Can be lipholized and shipped that can be used to cover the ulcer/wound, various sizes Now being used for burns and other wounds

AMNIOTIC MEMBRANE FOR WOUND HEALING RANDOMIZED TRIAL OF 25 PATIENTS WITH NON-HEALING LEG ULCERS Goal: Could Am Membrane promote wound healing and reconstruction vs scarring and fibrosis GP 1: STANDARD CARE/DAILIY DRESSING CHANGE GP 2: TOPICAL COVERING OF ULCER WITH AMNIOITIC MEMBRANE + DAILY DRESSING CHANGE Follow Up at Day 7, 14, 21, 30, 45, and 60 Assessed rate and amount of wound healing, ulcer depth, and self-assessed pain El Hanidy et al Int J Womens’s Health 2016

AMNIOTIC MEMBRANE FOR WOUND HEALING RESULTS GP 1: NO IMPROVEMENT IN WOUND HEALING ONLY 18% SHOWED ANY GRANULATION TISSUE NO IMPROVEMENT IN PAIN GP 2: ALL 14 PATIENTS HAD TOTAL WOUND HEALING WITHIN AVG 33 DAYS OF TREATMENT 13/14 HAD HEALTHY GRANULATION TISSUE 79% HAD SIGNIFICANT REDUCTION IN PAIN El Hanidy et al Int J Womens’s Health 2016

AMNIOTIC MEMBRANE FOR WOUND HEALING RESULTS GP 1: GP 2 TREATMENT Control Am Membrane Wound Healing 0/11 14/14 Granulation Tiss 2/11 13/14 Pain Reduction 0/11 13/14 El Hanidy et al Int J Womens’s Health 2016

Amniotic Fluid Membrane for Non-Healing Wounds

BIOELECTRIC STIMULATION FOR NON-HEALING ULCER

ADIPOSE DERIVED REGEN CELLS FOR CHRONIC LIMB ISCHEMIA 16 patients with CLI facing amputation ADRCs injected Intramuscularly along calf No complications of cell delivery RESULTS: 12/16 were spared amputation Very impressive wound healing Significant increase in blood flow by Angiogram Vaclav Prochazka Chech Repbulic

ADRCs for CLI

ADRCs for CLI PRE ADRCs POST ADRCs

CRITICAL LIMB ISCHEMIA NON-HEALING ULCER

CRITICAL LIMB ISCHEMIA NON-HEALING ULCER

CRITICAL LIMB ISCHEMIA NON-HEALING ULCER

CRITICAL LIMB ISCHEMIA NON-HEALING ULCER